Abstract
The high risk of neonatal death from sepsis is thought to result from impaired responses by innate immune cells; however, the clinical observation of hyperinflammatory courses of neonatal sepsis contradicts this concept. Using transcriptomic, epigenetic and immunological approaches, we demonstrated that high amounts of the perinatal alarmins S100A8 and S100A9 specifically altered MyD88-dependent proinflammatory gene programs. S100 programming prevented hyperinflammatory responses without impairing pathogen defense. TRIF-adaptor-dependent regulatory genes remained unaffected by perinatal S100 programming and responded strongly to lipopolysaccharide, but were barely expressed. Steady-state expression of TRIF-dependent genes increased only gradually during the first year of life in human neonates, shifting immune regulation toward the adult phenotype. Disruption of this critical sequence of transient alarmin programming and subsequent reprogramming of regulatory pathways increased the risk of hyperinflammation and sepsis. Collectively these data suggest that neonates are characterized by a selective, transient microbial unresponsiveness that prevents harmful hyperinflammation in the delicate neonate while allowing for sufficient immunological protection.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Expression of immune checkpoint molecules on adult and neonatal T-cells
Immunologic Research Open Access 23 November 2022
-
Mechanical control of innate immune responses against viral infection revealed in a human lung alveolus chip
Nature Communications Open Access 08 April 2022
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 per month
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$189.00 per year
only $15.75 per issue
Rent or buy this article
Get just this article for as long as you need it
$39.95
Prices may be subject to local taxes which are calculated during checkout







Accession codes
Change history
02 June 2017
In the version of this article initially published, the graphs in Figure 2e were incorrect. They have been replaced with the correct graphs. The error has been corrected in the HTML and PDF versions of the article.
References
Takeuchi, O. & Akira, S. Pattern recognition receptors and inflammation. Cell 140, 805–820 (2010).
Escoubet-Lozach, L. et al. Mechanisms establishing TLR4-responsive activation states of inflammatory response genes. PLoS Genet. 7, e1002401 (2011).
Fitzgerald, K.A. et al. LPS-TLR4 signaling to IRF-3/7 and NF-κB involves the toll adapters TRAM and TRIF. J. Exp. Med. 198, 1043–1055 (2003).
Yamamoto, M. et al. TRAM is specifically involved in the Toll-like receptor 4-mediated MyD88-independent signaling pathway. Nat. Immunol. 4, 1144–1150 (2003).
Biswas, S.K. & Lopez-Collazo, E. Endotoxin tolerance: new mechanisms, molecules and clinical significance. Trends Immunol. 30, 475–487 (2009).
Hoebe, K. et al. Upregulation of costimulatory molecules induced by lipopolysaccharide and double-stranded RNA occurs by Trif-dependent and Trif-independent pathways. Nat. Immunol. 4, 1223–1229 (2003).
Yamamoto, M. et al. Role of adaptor TRIF in the MyD88-independent Toll-like receptor signaling pathway. Science 301, 640–643 (2003).
Vogl, T., Leukert, N., Barczyk, K., Strupat, K. & Roth, J. Biophysical characterization of S100A8 and S100A9 in the absence and presence of bivalent cations. Biochim. Biophys. Acta 1763, 1298–1306 (2006).
Vogl, T. et al. Mrp8 and Mrp14 are endogenous activators of Toll-like receptor 4, promoting lethal, endotoxin-induced shock. Nat. Med. 13, 1042–1049 (2007).
Austermann, J. et al. Alarmins MRP8 and MRP14 induce stress tolerance in phagocytes under sterile inflammatory conditions. Cell Rep. 9, 2112–2123 (2014).
Liu, L. et al. Global, regional, and national causes of child mortality in 2000-13, with projections to inform post-2015 priorities: an updated systematic analysis. Lancet 385, 430–440 (2015).
Kollmann, T.R., Levy, O., Montgomery, R.R. & Goriely, S. Innate immune function by Toll-like receptors: distinct responses in newborns and the elderly. Immunity 37, 771–783 (2012).
Levy, O. Innate immunity of the newborn: basic mechanisms and clinical correlates. Nat. Rev. Immunol. 7, 379–390 (2007).
Zhao, J. et al. Hyper innate responses in neonates lead to increased morbidity and mortality after infection. Proc. Natl. Acad. Sci. USA 105, 7528–7533 (2008).
Foster, S.L., Hargreaves, D.C. & Medzhitov, R. Gene-specific control of inflammation by TLR-induced chromatin modifications. Nature 447, 972–978 (2007).
Barski, A. et al. High-resolution profiling of histone methylations in the human genome. Cell 129, 823–837 (2007).
Saeed, S. et al. Epigenetic programming of monocyte-to-macrophage differentiation and trained innate immunity. Science 345, 1251086 (2014).
Álvarez-Errico, D., Vento-Tormo, R., Sieweke, M. & Ballestar, E. Epigenetic control of myeloid cell differentiation, identity and function. Nat. Rev. Immunol. 15, 7–17 (2015).
Quintin, J., Cheng, S.C., van der Meer, J.W. & Netea, M.G. Innate immune memory: towards a better understanding of host defense mechanisms. Curr. Opin. Immunol. 29, 1–7 (2014).
Dowling, D.J. & Levy, O. Ontogeny of early life immunity. Trends Immunol. 35, 299–310 (2014).
Geng, H., Wittwer, T., Dittrich-Breiholz, O., Kracht, M. & Schmitz, M.L. Phosphorylation of NF-κB p65 at Ser468 controls its COMMD1-dependent ubiquitination and target gene-specific proteasomal elimination. EMBO Rep. 10, 381–386 (2009).
Tanaka, T., Grusby, M.J. & Kaisho, T. PDLIM2-mediated termination of transcription factor NF-κB activation by intranuclear sequestration and degradation of the p65 subunit. Nat. Immunol. 8, 584–591 (2007).
Saliba, D.G. et al. IRF5:RelA interaction targets inflammatory genes in macrophages. Cell Rep. 8, 1308–1317 (2014).
Weiss, M., Blazek, K., Byrne, A.J., Perocheau, D.P. & Udalova, I.A. IRF5 is a specific marker of inflammatory macrophages in vivo. Mediators Inflamm. 2013, 245804 (2013).
Yoza, B.K., Hu, J.Y., Cousart, S.L., Forrest, L.M. & McCall, C.E. Induction of RelB participates in endotoxin tolerance. J. Immunol. 177, 4080–4085 (2006).
Weighardt, H. et al. Type I IFN modulates host defense and late hyperinflammation in septic peritonitis. J. Immunol. 177, 5623–5630 (2006).
Achouiti, A. et al. Myeloid-related protein-14 contributes to protective immunity in gram-negative pneumonia derived sepsis. PLoS Pathog. 8, e1002987 (2012).
Corbin, B.D. et al. Metal chelation and inhibition of bacterial growth in tissue abscesses. Science 319, 962–965 (2008).
Achouiti, A. et al. Myeloid-related protein-8/14 facilitates bacterial growth during pneumococcal pneumonia. Thorax 69, 1034–1042 (2014).
Cho, H. et al. Calprotectin increases the activity of the SaeRS two component system and murine mortality during Staphylococcus aureus infections. PLoS Pathog. 11, e1005026 (2015).
Lissner, M.M. et al. Age-related gene expression differences in monocytes from human neonates, young adults, and older adults. PLoS One 10, e0132061 (2015).
Kanagavelu, S. et al. TIR domain-containing adapter-inducing beta interferon (TRIF) mediates immunological memory against bacterial pathogens. Infect. Immun. 83, 4404–4415 (2015).
Kolb, J.P., Casella, C.R., Sengupta, S., Chilton, P.M. & Mitchell, T.C. Type I interferon signaling contributes to the bias that Toll-like receptor 4 exhibits for signaling mediated by the adaptor protein TRIF. Sci. Signal. 7, ra108 (2014).
Wynn, J.L. et al. Postnatal age is a critical determinant of the neonatal host response to sepsis. Mol. Med. 21, 496–504 (2015).
Singh, V.V. et al. Decreased pattern recognition receptor signaling, interferon-signature, and bactericidal/permeability-increasing protein gene expression in cord blood of term low birth weight human newborns. PLoS One 8, e62845 (2013).
Cuenca, A.G. et al. Critical role for CXC ligand 10/CXC receptor 3 signaling in the murine neonatal response to sepsis. Infect. Immun. 79, 2746–2754 (2011).
Cuenca, A.G. et al. TRIF-dependent innate immune activation is critical for survival to neonatal gram-negative sepsis. J. Immunol. 194, 1169–1177 (2015).
Tanimura, N. et al. The attenuated inflammation of MPL is due to the lack of CD14-dependent tight dimerization of the TLR4/MD2 complex at the plasma membrane. Int. Immunol. 26, 307–314 (2014).
Wang, G.G. et al. Quantitative production of macrophages or neutrophils ex vivo using conditional Hoxb8. Nat. Methods 3, 287–293 (2006).
Viemann, D. et al. H5N1 virus activates signaling pathways in human endothelial cells resulting in a specific imbalanced inflammatory response. J. Immunol. 186, 164–173 (2011).
Theocharidis, A., van Dongen, S., Enright, A.J. & Freeman, T.C. Network visualization and analysis of gene expression data using BioLayout Express(3D). Nat. Protoc. 4, 1535–1550 (2009).
Maere, S., Heymans, K. & Kuiper, M. BiNGO: a Cytoscape plugin to assess overrepresentation of gene ontology categories in biological networks. Bioinformatics 21, 3448–3449 (2005).
Merico, D., Isserlin, R., Stueker, O., Emili, A. & Bader, G.D. Enrichment map: a network-based method for gene-set enrichment visualization and interpretation. PLoS One 5, e13984 (2010).
Oesper, L., Merico, D., Isserlin, R. & Bader, G.D. WordCloud: a Cytoscape plugin to create a visual semantic summary of networks. Source Code Biol. Med. 6, 7 (2011).
Fabregat, A. et al. The Reactome pathway Knowledgebase. Nucleic Acids Res. 44, D481–D487 (2016).
Janky, R. et al. iRegulon: from a gene list to a gene regulatory network using large motif and track collections. PLoS Comput. Biol. 10, e1003731 (2014).
Hansen, M. et al. pcaGoPromoter—an R package for biological and regulatory interpretation of principal components in genome-wide gene expression data. PLoS One 7, e32394 (2012).
Viemann, D. et al. Transcriptional profiling of IKK2/NF-κB- and p38 MAP kinase-dependent gene expression in TNF-α-stimulated primary human endothelial cells. Blood 103, 3365–3373 (2004).
Manitz, M.P. et al. Loss of S100A9 (MRP14) results in reduced interleukin-8-induced CD11b surface expression, a polarized microfilament system, and diminished responsiveness to chemoattractants in vitro. Mol. Cell. Biol. 23, 1034–1043 (2003).
Qin, H. et al. Generation of a new therapeutic peptide that depletes myeloid-derived suppressor cells in tumor-bearing mice. Nat. Med. 20, 676–681 (2014).
Acknowledgements
We thank U. Nordhues and A. Weitz for excellent technical support. We thank W. Kolanus, S. Burgdorf, M. Beyer and A. Schlitzer for critical reading of the manuscript. ER-Hoxb8 was kindly provided by the laboratory of G. Haecker (University Hospital of Freiburg, Freiburg, Germany). This work was supported by the Interdisciplinary Center of Clinical Research at the University of Muenster (grants Vo2/004/14 and Ro2/003/15 to T.V. and J.R.), the Cluster of Excellence Cells in Motion (T.V., J.R. and K.B.-K.), the collaborative research centers 1009 and TRR34 of the German Research Foundation (grants B8 and B9 and grant C13, respectively, to T.V., J.R. and K.B.-K.), the Appenrodt Foundation (D.V.), the German Research Foundation (grant VI 538/6-1 to D.V.), the Volkswagen Foundation (D.V.) and the German Research Foundation (grants SFB 832, SFB 704 and INST 217/577-1 to J.L.S.). J.L.S. is a member of the Cluster of Excellence ImmunoSensation and an associated member of the German epigenome program DEEP.
Author information
Authors and Affiliations
Contributions
T.U., S. Pirr, M.v.K.-B., J.L.S., J.R. and D.V. conceived and designed the experiments. B.F., M.S.B., T.G.L., T.V., L.M., A.S.H., J.B., J.S., S.S., S. Pfeifer, F.R., L.V., M.v.K.-B., K.B.-K., J.F., L.F.-R. and S.Z. performed experiments. T.U., S. Pirr, M.S., S.G., K.B.-K., J.L.S., J.R. and D.V. analyzed the data. T.U., S. Pirr, C.S.v.K., J.L.S., J.R. and D.V. wrote the manuscript.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Integrated supplementary information
Supplementary Figure 1 Experimental settings.
(a) Experimental setup and bioinformatic data analysis of transcriptomic changes induced in neonatal and adult monocytes by stimulation with 10 ng/ml LPS for 4h. QC/QA = quality control/quality assurance.
(b) Workflow for blood sampling from healthy infants (n = 127) and adults (n = 20).
(c) Timeline and workflow for S100a8/a9 pre-treatment and sepsis induction in S100a9−/− neonates.
Supplementary Figure 2 GOEA of LPS-induced changes in expression in human adult and neonatal monocytes.
Network visualization of GOEAs based on DE genes upon LPS treatment in adult (a) and neonatal (b) monocytes. Enriched GO-terms based on up-regulated DE genes are depicted by red nodes, based on down-regulated DE genes by blue borders. Color and size represent the corresponding FDR-adjusted enrichment P value (Q value). Overlap of genes between nodes is indicated by an edge.
Supplementary Figure 3 Hierarchical clustering (HC) and differences in protein expression between adult and neonatal monocytes.
(a-f) HC of genes enriched in the indicated GO clusters defined by GOEA of DE genes between the basal conditions. The z-scored log2 expression is displayed as heat map. (g) Extra- and intracellular flow cytometric analysis of protein expression of indicated MyD88- and TRIF-dependent genes in adult and neonatal monocytes 16h cultured with PBS (Ctrl) or LPS (each group n = 4). Bars represent means ± s.e.m. of mean fluorescence intensity (MFI). *P < 0.05, **P < 0.01, ***P < 0.0005 (unpaired t-test).
Supplementary Figure 4 Differences in MyD88- and TRIF-dependent gene expression between adult and neonatal mice.
(a) Relative basal gene expression of MyD88- and TRIF-dependent genes in murine adult and neonatal monocytes, determined by qRT-PCR. Bars represent means ± s.e.m. (n = 3). **P < 0.01, ***P < 0.005 (unpaired t-test). (b) LPS-induced fold changes (FC) of MyD88- and TRIF-dependent gene expression in murine adult and neonatal monocytes determined by qRT-PCR. Bars represent means ± s.e.m. (n = 3). *P < 0.05, **P < 0.01 (unpaired t-test.). (c) Plasma cytokine levels in adult and neonatal mice treated s.c. for 2h and 16h with 20 μg/g LPS or PBS (Ctrl). Bars represent means ± s.e.m. (adult: n = 8 (Ctrl), 6 (2h LPS) and 3 (16h LPS); neonatal: n = 6 (Ctrl), 4 (2h LPS) and 3 (16h LPS)). *P < 0.05, **P < 0.005, ***P < 0.0005 (unpaired t-test.).
Supplementary Figure 5 S100a9−/− neonates show a hyperinflammatory response to microbial challenges compared with wild-type neonates.
(a) Plasma cytokine levels in WT and S100a9−/− neonates 12h and 24h after infection with S. aureus. Bars represent means ± s.e.m (each group n = 5). *P < 0.05 (unpaired t-test). (b) Plasma cytokine levels in WT and S100a9−/− neonates 1.5h and 4h after s.c. injection of heat-inactivated S. aureus. Bars represent means ± s.e.m (each group n = 6 (1.5h), 5 (4h)). *P < 0.05, **P < 0.01 (unpaired t-test).
Supplementary Figure 6 S100A8/A9 induces inflammatory hyporesponsiveness and improves bacterial killing in human monocytes.
(a-c) Human adult and neonatal monocytes were isolated and cultured overnight in medium and, in case of adult monocytes, also in the presence of 10 μg/ml S100A8/A9 or 100 ng/ml S100A8 followed by challenges with PBS (Ctrl) or S. aureus (SA) (n = 4 in each group). Bars represent means ± s.e.m.. (a) IL-6 and TNF levels were determined in Ctrl and SA (1 MOI) supernatants 6h p.i.. * P < 0.05 (unpaired t-test). (b) Survival of SA in monocytes 3h (left panel) and 6h (right panel) after infection with 0.1 and 1.0 MOI SA. * P < 0.05, ** P < 0.01 (unpaired t-test). (c) Proportion of monocytes surviving 6h p.i. with 0.1 and 1.0 MOI SA. (d) Phagocytosis rate of adult and neonatal monocytes (each group n = 4) 30 min and 60 min after challenge with heat-killed SA. Bars represent means ± s.e.m..
Supplementary information
Supplementary Text and Figures
Supplementary Figures 1–6, Supplementary Tables 2 and 4–7, and Supplementary Note 1 (PDF 2876 kb)
Supplementary Table 1
List of genes significantly differentially expressed after induction by LPS (PDF 783 kb)
Supplementary Table 3
List of genes differentially expressed between adult and neonatal monocytes at baseline (PDF 1344 kb)
Rights and permissions
About this article
Cite this article
Ulas, T., Pirr, S., Fehlhaber, B. et al. S100-alarmin-induced innate immune programming protects newborn infants from sepsis. Nat Immunol 18, 622–632 (2017). https://doi.org/10.1038/ni.3745
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ni.3745
This article is cited by
-
Mechanical control of innate immune responses against viral infection revealed in a human lung alveolus chip
Nature Communications (2022)
-
Expression of immune checkpoint molecules on adult and neonatal T-cells
Immunologic Research (2022)
-
Sepsis des Frühgeborenen
Monatsschrift Kinderheilkunde (2021)
-
Impfen in der Schwangerschaft
Monatsschrift Kinderheilkunde (2021)
-
COVID-19 is a systemic vascular hemopathy: insight for mechanistic and clinical aspects
Angiogenesis (2021)